| Genome‐wide association studies of cognitive and motor progression in Parkinson's disease MMX Tan, MA Lawton, E Jabbari, RH Reynolds, H Iwaki, C Blauwendraat, ... Movement Disorders 36 (2), 424-433, 2021 | 133 | 2021 |
| L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression N Malek, S Kanavou, MA Lawton, V Pitz, KA Grosset, N Bajaj, RA Barker, ... Parkinsonism & Related Disorders 65, 55-61, 2019 | 19 | 2019 |
| Neuromelanin‐MRI to quantify and track nigral depigmentation in Parkinson's disease: A multicenter longitudinal study using template‐based standardized analysis Y Xing, AH Sapuan, A Martín‐Bastida, S Naidu, C Tench, J Evans, G Sare, ... Movement Disorders 37 (5), 1028-1039, 2022 | 16 | 2022 |
| Olfactory testing in Parkinson disease and REM behavior disorder: a machine learning approach C Lo, S Arora, Y Ben-Shlomo, TR Barber, M Lawton, JC Klein, S Kanavou, ... Neurology 96 (15), e2016-e2027, 2021 | 15 | 2021 |
| Testing shortened versions of smell tests to screen for hyposmia in Parkinson's disease SD Auger, S Kanavou, M Lawton, Y Ben‐Shlomo, MT Hu, AE Schrag, ... Movement Disorders Clinical Practice 7 (4), 394-398, 2020 | 12 | 2020 |
| Optimising classification of Parkinson’s disease based on motor, olfactory, neuropsychiatric and sleep features JP Bestwick, SD Auger, AE Schrag, DG Grosset, S Kanavou, ... npj Parkinson's Disease 7 (1), 87, 2021 | 5 | 2021 |
| Comparison between four published definitions of hyposmia in Parkinson's disease S Kanavou, V Pitz, MA Lawton, N Malek, KA Grosset, HR Morris, ... Brain and Behavior 11 (8), e2258, 2021 | 4 | 2021 |
| Maximising information on smell, quantitative motor impairment and probable REM-sleep behaviour disorder in the prediction of Parkinson’s disease JP Bestwick, SD Auger, AE Schrag, DG Grosset, S Kanavou, ... MedRxiv, 2020.03. 03.20023994, 2020 | 3 | 2020 |
| Genome-wide association studies of motor and cognitive progression in Parkinson's disease M Tan, L Hubbard, M Lawton, S Kanavou, N Wood, J Hardy, ... MOVEMENT DISORDERS 33, S630-S630, 2018 | 2 | 2018 |
| Genome-wide determinants of mortality and motor progression in Parkinson’s disease MM Tan, MA Lawton, MI Pollard, E Brown, R Real, S Bekadar, E Jabbari, ... | 1 | 2022 |
| Genome-wide determinants of mortality and clinical progression in Parkinson’s disease MMX Tan, MA Lawton, MI Pollard, E Brown, S Bekadar, E Jabbari, ... medRxiv, 2022.07. 07.22277297, 2022 | | 2022 |
| 228 Testing shortened versions of smell tests to screen for hyposmia in Parkinson’s disease S Auger, S Kanavou, M Lawton, Y Ben-Shlomo, M Hu, A Schrag, H Morris, ... Journal of Neurology, Neurosurgery and Psychiatry 93 (6), A79-A79, 2022 | | 2022 |
| Genome-wide determinants of mortality and clinical progression in Parkinson’s disease (preprint) MMX Tan, M Lawton, M Pollard, E Brown, S Bekadar, E Jabbari, ... | | 2022 |
| Evaluation Of The Rims2 Locus As A Risk Locus For Parkinson’s Disease Dementia MXT Manuela, R Raquel, AL Michael, B Catherine, S Kanavou, T Foltynie, ... medRxiv, 2021.07. 26.21261131, 2021 | | 2021 |
| Genome-wide association studies of progression in Parkinson's disease: 510 M Tan, M Shoai, M Lawton, S Kanavou, N Wood, J Hardy, Y Ben-Shlomo, ... Movement Disorders 35, 2020 | | 2020 |
| Genome-wide association studies of progression in Parkinson's disease M Tan, M Shoai, M Lawton, S Kanavou, N Wood, J Hardy, Y Ben-Shlomo, ... MOVEMENT DISORDERS 35, S213-S213, 2020 | | 2020 |
| Improving estimation of Parkinson's disease risk-enhancing the PREDICT-PD algorithm J Bestwick, S Auger, D Grosset, S Kanavou, G Giovannoni, A Lees, ... MOVEMENT DISORDERS, 2020 | | 2020 |
| Audio-recording recruitment consultations-an exploratory study in two RCTs to investigate the impact on randomisation rates C Rogers, S Paramasivan, D Elliott, P Whybrow, S Kanavou, RA Harris, ... TRIALS 18, 2017 | | 2017 |
| Olfactory Testing in Parkinson Disease and REM Behavior Disorder: a machine learning approach. Neurology, 96 (15), e2016-e2027. C Lo, Y Ben-Shlomo, MA Lawton, S Kanavou | | |
